不论是品牌药还是非专利药,谁为药钱买单?
这一道理适用于成百上千种物品,从专利药到漂白剂再到香料。
True of hundreds of items from patent medicines to bleach to spices.
另外一项挑战是购买足够的螯合剂:这属于昂贵的药物,没有非专利药。
A further challenge is the purchase of sufficient chelating agents: these are expensive drugs that are not available as generics.
这个月早些时候,美国的联邦贸易委员会将这项调查扩大到了非专利药公司。
Earlier this month, America's FTC extended its probe to include generics companies.
辉瑞和其它大制药公司一样都面临着非专利药的威胁,辉瑞公司正进行战略性收缩和重塑。
Like many big pharmas facing a generics threat, Pfizer is slimming down and restructuring.
目的为专利药降价提供参考和备选路径。
Objective to offer several ways to reduce prices of proprietary drugs.
在那时,没有允许快速注册非专利药的机制。
At that time, there were no mechanisms to allow quick registration of generics.
作为单一成分出售的辛伐他汀是非专利药,商品名为舒降之。
Simvastatin is sold as a single-ingredient generic medication and as the brand-name Zocor.
他们鼓励医生给患者开较便宜的非专利药,而不是价格更高的品牌药。
They encourage doctors to prescribe cheaper generic drugs instead of more expensive brand names.
如同亚洲其它新兴制药部门一样,韩国制药工业已把主要精力放在了非专利药上。
Like many other emerging pharmaceutical sectors in Asia, the South Korean pharmaceutical industry has concentrated most of its efforts in generics.
这些非专利药品和专利药完全一样,只是没有品牌名称,也就是不向医药公司支付巨额专利费。
They are the exact same product, but without the brand name — or the fat patent payments to drug companies.
在花少量的钱就能治好的情况下,给感冒流鼻涕这些的常见病开出昂贵的专利药毫无意义。
It makes no sense to prescribe an expensive patented medicine for the sniffles when something that costs cents will do the job.
2012年,辉瑞失去了对这种药物的专有权,生产廉价非专利药的公司将和它展开竞争。
In 2012, Pfizer lost the exclusive rights to the drug, opening it up to competition from companies that produce cheaper, generic versions.
从治疗致命疾病的药品到止痛药和抗组胺药等价格低廉的非专利药品,各种药物都有造假的情况出现。
All kinds of medicines have been counterfeited, from medicines for the treatment of life-threatening conditions to inexpensive generic versions of painkillers and antihistamines.
中国的政策支持会更进一步降低仿制药的价格,这会给药品研发机构及国际非专利药公司带来深远影响。
Chinese policy will drive generic prices down still further, with far-reaching consequences for both R&D players and international generic companies.
一个世界卫生组织令人惊喜的研究展现了非专利药对治疗艾滋病的抗逆转录病毒复合药和鸡尾酒药的影响。
This is a fascinating research from WHO that shows the effect of generic drugs on anti-retroviral drug compounds and cocktails.
无品牌非专利药会使药品竞争异常激烈,以美国为例,某专利药在保护期到期后的一年内其价格降幅会超过85%。
Where competition from unbranded generics is fiercest, for instance in America, the price of a given drug falls by more than 85% within a year of patent expiry.
通常情况下,非专利药比品牌药便宜20% - 80%,病人以及帮处方药买单的企业和纳税人都将从中获益。
Patients, businesses and taxpayers who help pay for prescription drugs will save a fortune because generic drugs typically cost 20 percent to 80 percent less than the brand names.
由于大型制药公司的重点产品许多面临专利过期,患者纷纷转向非专利药,这些公司还面临要不断开发新药品的任务。
The big pharmaceutical companies are also struggling to refill their product pipelines with new offerings as their blockbuster drugs' patents expire and patients switch to generics.
华海药业负责北美和日本市场销售的区域代表JessicaYu说,目前,我们认为还不具备从事专利药研究的能力或技术知识。
'Currently, we don't think we have that kind of capability or technical knowledge of doing a patent,' says Jessica Yu, Huahai's regional representative for North American and Japanese drug sales.
虽然还有数家企业也在生产乙脑疫苗,但中国产的这款单剂型疫苗是首个获批用于儿童患者身上的此类疫苗,这为该产品参与低价非专利药竞争铺平了道路。
While several other manufacturers make similar JE vaccines, the new single-dose Chinese product is the first to be approved for paediatric use and paves the way for cut-price generic competition.
虽然还有数家企业也在生产乙脑疫苗,但中国产的这款单剂型疫苗是首个获批用于儿童患者身上的此类疫苗,这为该产品参与低价非专利药竞争铺平了道路。
While several other manufacturers make similar JE vaccines, the new single-dose Chinese product is the first to be approved for paediatric use and paves the way for cut-price generic competition.
应用推荐